156 related articles for article (PubMed ID: 32816944)
1. Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma.
Chong WQ; Lim CM; Sinha AK; Tan CS; Chan GHJ; Huang Y; Kumarakulasinghe NB; Sundar R; Jeyasekharan AD; Loh WS; Tay JK; Yadav K; Wang L; Wong AL; Kong LR; Soo RA; Lau JA; Soon YY; Goh RM; Ho FCH; Chong SM; Lee SC; Loh KS; Tai BC; Lim YC; Goh BC
Clin Cancer Res; 2020 Oct; 26(20):5320-5328. PubMed ID: 32816944
[TBL] [Abstract][Full Text] [Related]
2. Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.
Fang W; Yang Y; Ma Y; Hong S; Lin L; He X; Xiong J; Li P; Zhao H; Huang Y; Zhang Y; Chen L; Zhou N; Zhao Y; Hou X; Yang Q; Zhang L
Lancet Oncol; 2018 Oct; 19(10):1338-1350. PubMed ID: 30213452
[TBL] [Abstract][Full Text] [Related]
3. A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.
Murray Stewart T; Von Hoff D; Fitzgerald M; Marton LJ; Becerra CHR; Boyd TE; Conkling PR; Garbo LE; Jotte RM; Richards DA; Smith DA; Stephenson JJ; Vogelzang NJ; Wu HH; Casero RA
Cancer Chemother Pharmacol; 2021 Jan; 87(1):135-144. PubMed ID: 33215270
[TBL] [Abstract][Full Text] [Related]
4. Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.
Mai HQ; Chen QY; Chen D; Hu C; Yang K; Wen J; Li J; Shi YR; Jin F; Xu R; Pan J; Qu S; Li P; Hu C; Liu YC; Jiang Y; He X; Wang HM; Lim WT; Liao W; He X; Chen X; Liu Z; Yuan X; Li Q; Lin X; Jing S; Chen Y; Lu Y; Hsieh CY; Yang MH; Yen CJ; Samol J; Feng H; Yao S; Keegan P; Xu RH
Nat Med; 2021 Sep; 27(9):1536-1543. PubMed ID: 34341578
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of a phase II study of gemcitabine and cisplatin chemotherapy combined with intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
Wu M; Ou D; He X; Hu C
Oral Oncol; 2017 Oct; 73():118-123. PubMed ID: 28939063
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of two different adjuvant chemotherapy regimens in combination with concurrent chemoradiotherapy in treating patients with advanced nasopharyngeal carcinoma: A protocol for randomized controlled trial.
Zhang LL; Cui J; Tan HF; Xiao Z; Pan LX
Medicine (Baltimore); 2021 May; 100(21):e25980. PubMed ID: 34032710
[TBL] [Abstract][Full Text] [Related]
7. SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma.
Geldart T; Chester J; Casbard A; Crabb S; Elliott T; Protheroe A; Huddart RA; Mead G; Barber J; Jones RJ; Smith J; Cowles R; Evans J; Griffiths G
Eur Urol; 2015 Apr; 67(4):599-602. PubMed ID: 25465968
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study.
Hong S; Zhang Y; Yu G; Peng P; Peng J; Jia J; Wu X; Huang Y; Yang Y; Lin Q; Xi X; Xu M; Chen D; Lu X; Wang R; Cao X; Chen X; Lin Z; Xiong J; Lin Q; Xie C; Li Z; Pan J; Li J; Wu S; Lian Y; Yang Q; Zhao C; Fang W; Zhang L
J Clin Oncol; 2021 Oct; 39(29):3273-3282. PubMed ID: 34379443
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.
Zhang Y; Chen L; Hu GQ; Zhang N; Zhu XD; Yang KY; Jin F; Shi M; Chen YP; Hu WH; Cheng ZB; Wang SY; Tian Y; Wang XC; Sun Y; Li JG; Li WF; Li YH; Tang LL; Mao YP; Zhou GQ; Sun R; Liu X; Guo R; Long GX; Liang SQ; Li L; Huang J; Long JH; Zang J; Liu QD; Zou L; Su QF; Zheng BM; Xiao Y; Guo Y; Han F; Mo HY; Lv JW; Du XJ; Xu C; Liu N; Li YQ; Chua MLK; Xie FY; Sun Y; Ma J
N Engl J Med; 2019 Sep; 381(12):1124-1135. PubMed ID: 31150573
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
Zhang L; Huang Y; Hong S; Yang Y; Yu G; Jia J; Peng P; Wu X; Lin Q; Xi X; Peng J; Xu M; Chen D; Lu X; Wang R; Cao X; Chen X; Lin Z; Xiong J; Lin Q; Xie C; Li Z; Pan J; Li J; Wu S; Lian Y; Yang Q; Zhao C
Lancet; 2016 Oct; 388(10054):1883-1892. PubMed ID: 27567279
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study.
Kanda S; Goto K; Shiraishi H; Kubo E; Tanaka A; Utsumi H; Sunami K; Kitazono S; Mizugaki H; Horinouchi H; Fujiwara Y; Nokihara H; Yamamoto N; Hozumi H; Tamura T
Ann Oncol; 2016 Dec; 27(12):2242-2250. PubMed ID: 27765756
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine combined with cisplatin vs. taxane, cisplatin, and fluorouracil in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective case-control study.
Huang YM; Qiao SQ; Lu L; Chen WP; Li SL; Qi CH
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7655-7663. PubMed ID: 32744691
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study.
Kong XY; Lu JX; Yu XW; Zhang J; Xu QL; Zhang RJ; Mi JL; Liao SF; Fan JF; Qin XL; Yao DC; Tang HY; Jiang W
Cancer Chemother Pharmacol; 2019 Jul; 84(1):155-161. PubMed ID: 31087135
[TBL] [Abstract][Full Text] [Related]
14. Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma.
Gu MF; Liu LZ; He LJ; Yuan WX; Zhang R; Luo GY; Xu GL; Zhang HM; Yan CX; Li JJ
Int J Cancer; 2013 Jan; 132(1):215-23. PubMed ID: 22610788
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma.
Yau TK; Lee AW; Wong DH; Yeung RM; Chan EW; Ng WT; Tong M; Soong IS
Head Neck; 2006 Oct; 28(10):880-7. PubMed ID: 16721741
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine and Cisplatin followed by chemo-radiation for advanced nasopharyngeal carcinoma.
Jamshed A; Hussain R; Iqbal H
Asian Pac J Cancer Prev; 2014; 15(2):899-904. PubMed ID: 24568516
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Am J Clin Oncol; 2005 Oct; 28(5):464-71. PubMed ID: 16199985
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy of neoadjuvant chemotherapy with gemcitabine plus cisplatin versus docetaxil, cisplatin, plus fluorouracil in locally advanced nasopharyngeal carcinoma.
Rehman A; Haider G; Ramchand A; Anaum -; Nawaz Khan S; Mahar F; Mahmood R; Saher S; Khattak YR; Aqeel MA
Pak J Pharm Sci; 2024 Mar; 37(2):377-383. PubMed ID: 38767105
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China.
Zang J; Xu M; Li C; Zhao L; Luo S; Wang J; Shi M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2369-2378. PubMed ID: 32363479
[TBL] [Abstract][Full Text] [Related]
20. Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma.
Zhang Y; Sun Y; Ma J
Cancer Commun (Lond); 2019 Jun; 39(1):39. PubMed ID: 31238975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
